Tobinick, Edward Lewis, M.D. Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2004
NCT00203359
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now